J. Salmanton-García Et Al. , "Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry," International Journal of Antimicrobial Agents , vol.62, no.4, 2023
Salmanton-García, J. Et Al. 2023. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. International Journal of Antimicrobial Agents , vol.62, no.4 .
Salmanton-García, J., Marchesi, F., Koehler, P., Weinbergerová, B., Čolović, N., Falces-Romero, I., ... Buquicchio, C.(2023). Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. International Journal of Antimicrobial Agents , vol.62, no.4.
Salmanton-García, Jon Et Al. "Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry," International Journal of Antimicrobial Agents , vol.62, no.4, 2023
Salmanton-García, Jon Et Al. "Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry." International Journal of Antimicrobial Agents , vol.62, no.4, 2023
Salmanton-García, J. Et Al. (2023) . "Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry." International Journal of Antimicrobial Agents , vol.62, no.4.
@article{article, author={Jon Salmanton-García Et Al. }, title={Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry}, journal={International Journal of Antimicrobial Agents}, year=2023}